Ipamorelin
10mgVolume Pricing
Per unit — bulk discounts applied automaticallyWholesale pricing available for approved accounts
About Ipamorelin
A selective growth hormone secretagogue pentapeptide composed of 5 amino acids. Demonstrates high selectivity for the ghrelin/GHS receptor with minimal effect on cortisol, prolactin, or ACTH in research models.
Frequently Asked Questions
All Signal peptides undergo rigorous third-party testing and are guaranteed ≥99% purity. Every batch comes with a Certificate of Analysis (COA) verified through AuthentiChain's blockchain verification system.
Orders placed before 12PM EST ship same-day via cold chain logistics. Products are shipped in insulated packaging with dry ice to maintain temperature integrity. Standard delivery is 1–3 business days.
Approved accounts have access to flexible payment terms including NET 30, wire transfer, and credit card. Volume-based pricing is automatically applied at checkout based on your order quantity.
Absolutely. Contact your dedicated account manager or reach out to info@signalpeps.com with the product name and lot number. COAs are also available digitally through our AuthentiChain verification badge on each product page.
Published Study Findings on Ipamorelin
Detailed Research & Citations
In-depth findings from peer-reviewed preclinical and clinical studies
Ipamorelin is a selective growth hormone secretagogue pentapeptide that binds the ghrelin/GHS-R1a receptor with high specificity, stimulating GH release without affecting cortisol, ACTH, or prolactin levels.
Selective Growth Hormone Stimulation
Ipamorelin selectively stimulated growth hormone release via the GHS-R1a receptor without significantly elevating ACTH, cortisol, FSH, LH, prolactin, or TSH — demonstrating high endocrine specificity among GH secretagogues.
European Journal of Endocrinology (1998)Potent GH Elevation
In controlled experimental settings, Ipamorelin demonstrated dose-dependent GH release with corresponding elevations in IGF-1. Human pharmacokinetic studies showed a terminal half-life of approximately 2 hours with peak GH release at ~40 minutes post-administration.
Journal of Clinical Pharmacology (1999)Longitudinal Bone Growth Stimulation
Ipamorelin dose-dependently increased longitudinal bone growth rate in animal models and counteracted the decrease in bone formation induced by glucocorticoid (dexamethasone) treatment.
Growth Hormone & IGF Research (2001)Bone Mineral Content Preservation
In glucocorticoid-treated rats, Ipamorelin treatment preserved total body bone mineral content and promoted bone formation markers, suggesting protective effects against corticosteroid-induced bone loss.
Endocrinology (2000)View All 4 Sources
- Ipamorelin, the first selective growth hormone secretagogue
- Safety, pharmacokinetics, and pharmacodynamics of ipamorelin in healthy volunteers
- The growth hormone secretagogue ipamorelin counteracts glucocorticoid-induced decrease in bone formation of adult rats
- Effects of growth hormone-releasing peptide-6 and other related secretagogues on bone growth
All findings above are sourced from peer-reviewed journals for educational reference. This product is for research purposes only — not for human consumption. Preclinical results may not translate to human outcomes.
Chemical Identity
How to Order
Three simple steps to access premium research peptides
Apply for an Account
Submit a quick application with your business details. Takes less than 2 minutes.
Get Approved
Our team reviews applications within 1–2 business days. You'll receive an email once approved.
Place Your Order
Browse the catalog, select quantities, and checkout. Volume pricing applies automatically.
All products are for research and laboratory purposes only. Not intended for human or animal consumption. Only qualified professionals should handle these products.
